The epigallocatechin gallate derivative Y(6) reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo

Previously, we reported that Y(6), a new epigallocatechin gallate derivative, is efficacious in reversing doxorubicin (DOX)--mediated resistance in hepatocellular carcinoma BEL-7404/DOX cells. In this study, we evaluated the efficacy of Y(6) in reversing drug resistance both in vitro and in vivo by...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yan, Zhao, Ruiqiang, Gupta, Pranav, Fan, Yingfang, Zhang, Yunkai, Huang, Zhenguang, Li, Xiaohui, Su, Yuangang, Liao, Lijuan, Xie, Yu-An, Yang, Donghua, Chen, Zhe-Sheng, Liang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437594/
https://www.ncbi.nlm.nih.gov/pubmed/30972279
http://dx.doi.org/10.1016/j.apsb.2018.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437594/
https://www.ncbi.nlm.nih.gov/pubmed/30972279
http://dx.doi.org/10.1016/j.apsb.2018.10.001

Ejemplares similares